One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized ...

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...

In an industry-sponsored trial, investigators evaluated the long-term efficacy of a bivalent vaccine against HPV types 16 and 18 in 776 women who participated in an earlier randomized controlled ...

A vaccine that blocks infection with the human papillomavirus has helped to lower cervical cancer rates. Researchers want to ...

The country's free immunization program currently includes 14 vaccines that protect against 15 diseases. National coverage ...

Cecolin, a bivalent HPV shot developed by Beijing ... With additional domestic-developed HPV vaccines expected to be launched ...

The bivalent vaccine has, until Tuesday’s changes to the emergency use authorizations for the Moderna and Pfizer-BioNTech vaccines, only been approved for use as a booster vaccine. With Tuesday ...

SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it completed enrollment of its Phase 1 clinical trial evaluating its second-generation ...

Bivalent: Protects against HPV types 16 and 18 ... 58). The nonavalent vaccine provides the broadest protection, covering nearly all HPV-related diseases and cancers. Ages 9-14: Two doses at ...

Partnering with dental clinics to offer HPV vaccines to eligible children and adolescents improved vaccination rates by more ...